Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02682316 · ClinicalTrials.gov registry record · Phase 3

Negative Pressure Wound Therapy in Post-Operative Incision Management

A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
Phase 3
Development phase
583
Enrollment target

NCT02682316: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT02682316 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 583 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02682316, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
Phase 3
Development phase
583 participants
Enrollment target

Study Summary

The purpose of this study is to compare any good and bad effects of using the Prevena Incision Management System to using the usual standard dry gauze approach. The Prevena Incision Management System is a type of Negative Pressure Wound Therapy (NPWT). NPWT is a portable vacuum device made of a sponge-like foam that is applied over your incision to help draw fluid and debris out after surgery.

Primary Outcome

Incidence of inpatient post-operative wound complications will be documented through the use of an inpatient data collection sheet. Incidence of outpatient post-operative wound complication will be documented through the use of an outpatient data collection sheet that will be completed by a provider at the time of the routine post-operative follow-up visit, which will occur at 30 days +/- 5 days after the day of surgery as well as through ongoing documentation of events as elicited through the i

Interventions

  • OTHER dry gauze
  • DEVICE The Prevena Incision Management System

Trial Details

FieldValue
Enrollment Target 583 participants
Start Date 2016-02
Est. Completion 2024-01-25
Phase Phase 3
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT02682316 record still lists

NCT02682316 is an interventional study that assigns participants to a tested intervention. The registered 583 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% lower).

The record links to 0 conditions, and to 2 interventions - of which dry gauze is the first listed.

NCT02682316 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02682316 about?

NCT02682316 is a clinical study titled "Negative Pressure Wound Therapy in Post-Operative Incision Management". The purpose of this study is to compare any good and bad effects of using the Prevena Incision Management System to using the usual standard dry gauze approach. The Prevena Incision Management System is a type of Negative Pressure Wound Therapy (NPWT). NPWT is a portable vacuum device made of a spon...

What is the current status of trial NCT02682316?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 583 participants. The study started on 2016-02. Estimated completion is 2024-01-25.

What interventions are being tested in trial NCT02682316?

The interventions under investigation include: dry gauze (OTHER), The Prevena Incision Management System (DEVICE).

Who is sponsoring clinical trial NCT02682316?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02682316's enrollment target sits among peer trials

583 652nd of 2000 higher than 1,348 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03840083 · 584 participants · NA

    Sleep-dependent Learning in Aging

  • NCT04984291 · 584 participants · NA

    Zimmer Biomet Shoulder Arthroplasty PMCF

  • NCT05983757 · 584 participants · NA

    Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

  • NCT06569290 · 584 participants · NA

    Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02682316, the US trial registry maintained by the National Library of Medicine. NCT02682316 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.